Group health cover in the Philippines: the annual ceiling.

In short: A Philippine group HMO is governed by its Maximum Benefit Limit — Maxicare’s published tiers run from ₱100,000 to ₱250,000 a year. That ceiling is not per illness. It is a single annual pool per member covering consultations, diagnostics and hospitalisation together, replenished at renewal rather than carried forward. PhilHealth sits underneath it as an employer obligation, paying fixed case rates per condition rather than a share of the bill.

A benefits manager renews the Philippine group plan the way most renewals happen: the local administrator sends a one-page comparison, the premium moved a manageable amount, the network looks the same, sign here. Nobody opens the actual plan schedule and reads the number that governs the whole policy — the Maximum Benefit Limit. It sits on Maxicare’s own published tiers at somewhere between ₱100,000 and ₱250,000 a year, and it is not per illness. It is a single annual pool for that member covering consultations, diagnostics and hospitalisation combined. A plan that reads as generous benefit-by-benefit can still be a ceiling one serious admission clears before the second week of treatment is over.

That is the operational error we see most often in a Philippine group programme, and it is worth stating plainly because almost nobody outside the contract itself does: a local HMO and international health cover are not the same category of product, and the difference shows up exactly when a company can least afford to discover it — mid-claim, for an employee who is actually sick.

The ceiling problem, in the numbers insurers publish themselves

Local HMOs are the standard Philippine employee benefit for good reason. They are affordable, they run on accredited networks with cashless outpatient access, and for the ordinary run of consultations and minor treatment they work exactly as advertised. The design only strains at the top of the policy, where two mechanics compound each other.

The first is the ceiling itself. Maxicare’s own consumer plan page states Maximum Benefit Limits by tier — Platinum Plus at ₱250,000, Platinum at ₱200,000, Gold at ₱150,000, Silver at ₱100,000 — and is explicit that the figure is inclusive of consultations, diagnostics and hospitalisation together, not a separate allowance for each. The second is what happens once that number is reached. MediCard’s own Standard Healthcare Program Agreement states the limit is replenished at renewal, meaning nothing unused carries forward and nothing spent refills mid-term — and that foreign-territory emergency care is reimbursed only up to roughly ₱30,000 a year, an amount that covers very little of an actual evacuation. That second figure is one we are still working to confirm against a full primary read of the agreement, so we flag it as pending rather than settled — but the mechanic it describes, a limit that does not roll over, is consistent with how the product category is built.

Put those two mechanics together and the exposure is specific: one employee, one bad diagnosis, and the pool that was meant to last the policy year is gone in days — for that person, for the rest of that renewal cycle. A young, healthy census makes this invisible for years, which is exactly why it survives renewal after renewal unread. It becomes visible the one year it matters, on the one employee it happens to.

It also concentrates unevenly across a workforce spread beyond Metro Manila. The accredited networks the major HMOs run are strongest in the capital, Cebu and a handful of other cities; staff posted to a provincial office or a site outside those networks are typically the ones who need a referral or transfer to reach the level of hospital their case requires. Neither PhilHealth nor a standard HMO agreement is built to fund that movement — the domestic layer pays for care received inside its own network, not the cost of reaching it. For a company with people outside the Manila–Cebu–Davao triangle, that is a second, quieter version of the same ceiling question: not just how much the plan pays, but where it will actually pay it.

PhilHealth sits underneath, not instead

For a company employing foreign staff in the Philippines, PhilHealth is not a benefit decision — it is a payroll one. Formally employed foreigners are enrolled by their employer, with a premium shared between employer and employee and calculated on salary. That obligation runs alongside whatever HMO or international cover the company chooses; it does not replace the need for one.

What PhilHealth pays is also structurally different from what a company buying protection usually assumes. It pays a fixed case rate per condition — a set peso amount per diagnosis — not a percentage of the bill. That makes it a genuine subsidy and a poor substitute for cover: it reduces a bill, it does not cap a company’s or an employee’s exposure to one. We put numbers on that in what PhilHealth actually buys a foreigner. Treating the PhilHealth line on a compliance checklist as though it answers the same question as the HMO line is the second version of the same mistake — reading a floor as a ceiling.

PhilHealth opened its doors to foreign nationals back in 2017, so for a company that has employed internationally in the Philippines for any length of time, the enrolment itself is rarely the gap. What we more often find missing on review is the paper trail: whether HR can point to the PhilHealth Identification Number for each foreign employee, confirm the deduction is actually landing on the payslip, and say with confidence which of PhilHealth, the HMO and — where it exists — an international layer is meant to answer which kind of claim. Three products, three different jobs, and a company that has only ever checked the first one is compliant on paper and still exposed everywhere it matters.

What it costs to close the gap

Here is the number that makes closing this gap an easier decision in the Philippines than in most of the markets we review programmes for. In the SIP Health Cost Index 2025 — fifty countries, comparable international cover — the Philippines ranks 41st of 50, averaging about $6,842 a year across the age bands we track: roughly $4,800 at 24, $6,482 at 35, $9,243 at 50. That is among the cheapest countries in Asia for real international cover, at under half the Singapore figure of $14,231. For a company already running a Philippine office alongside a Singapore or Hong Kong one, the Philippine line item is the one least likely to strain the regional benefits budget — which makes it a reasonable place to close the ceiling gap properly rather than patch it with a higher HMO tier that still resets to zero at renewal.

Worth reading the age bands inside that index number too, since a group scheme is priced on its census, and a census only moves in one direction. The same data that puts the 24-year-old profile at roughly $4,800 puts the 50-year-old profile at roughly $9,243 — the cost of comparable cover still climbs with age here, even though the Philippines as a whole sits near the affordable end of the fifty countries we track. A quote built on this year’s census tells a company what this year costs, not what the same population costs once it has aged through a few renewal cycles — worth factoring into a multi-year budget rather than assuming next year repeats this one.

None of this argues against the local HMO — for the routine care most employees use most years, it remains the right, affordable base. The argument is narrower and more specific: know the number the policy is actually built around, know what happens once it is reached, and decide deliberately whether the gap above it is one the company is comfortable carrying itself.

How the review works

Send the shape through our companies page: headcount, the countries your workforce sits in, and your renewal date. Within about a working day an adviser replies in writing with a scope — what your current Maximum Benefit Limit actually is against a realistic serious-illness bill, what resets at renewal versus what your policy claims to carry forward, where PhilHealth’s employer obligation and your HMO or international layer overlap or leave a gap, and, where it is true, that the programme you already have is well built and should be left alone.

We are advisers, not a carrier: anything we eventually place runs through SIP’s licences on a courtage basis we publish, and the review costs nothing whichever way it ends. The moment that matters here is before the next renewal signature, not after a claim finds the ceiling for you.